Last reviewed · How we verify

Oral sulfate solution (OSS)

Bo-In Lee · FDA-approved active Small molecule

Oral sulfate solution acts as an osmotic laxative by drawing water into the intestinal lumen to promote bowel evacuation.

Oral sulfate solution acts as an osmotic laxative by drawing water into the intestinal lumen to promote bowel evacuation. Used for Bowel preparation prior to colonoscopy or other gastrointestinal procedures, Treatment of constipation.

At a glance

Generic nameOral sulfate solution (OSS)
Also known asSUPREP, Sodium potassium magnesium sulfate oral concentrated solution, Suclear® solution (Phambio Korea, Seoul, Korea)
SponsorBo-In Lee
Drug classOsmotic laxative
ModalitySmall molecule
Therapeutic areaGastroenterology
PhaseFDA-approved

Mechanism of action

Sulfate ions are poorly absorbed in the gastrointestinal tract and create an osmotic gradient that increases intraluminal fluid volume, stimulating peristalsis and facilitating stool passage. This mechanism is commonly used for bowel preparation and treatment of constipation without systemic absorption of the active ingredient.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: